首页> 外文OA文献 >Upotreba periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima--prikaz vlastitih iskustava The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience
【2h】

Upotreba periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima--prikaz vlastitih iskustava The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience

机译:患者恶性血液病外围介​​绍中心静脉导管(pICC)的使用 - 分享你的经验患者的血液系统恶性肿瘤的使用外周中心静脉置管的(pICC) - 单中心经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM. In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies. ----- METHODSududIn the period from 2009 to 2012, a total of 105 PICCs were inserted in 90 patients. Patients with Non-Hodgkin lymphoma treated with DA-EPOCH comprised almost 40% of the cohort. ----- RESULTSududThe total PICC in-dwell time was 14781 days with a median of 129 days (range 8-570 days). Malposition of the PICC occurred in 12 patients (11.4%) with a successful reposition or re-insertion. In 39 patients (37%) PICC was removed before the end of treatment due to suspected or proven infection (30 patients, 29%; 2.03 per 1000 PICC days), thrombosis associated with PICC in four patients (3.8%), occlusion of the PICC (two patients), misplaced catheter (two patients), and suspected thromboembolism in a single patient. ----- CONCLUSIONududPICC is a safe and convenient long-term venous access in patients with hematological malignancies.
机译:目标。在这项研究中,我们介绍了血液系统恶性肿瘤患者外周静脉置入中心静脉导管(PICC)的经验。 -----方法 ud ud在2009年至2012年期间,共90例患者插入了105例PICC。接受DA-EPOCH治疗的非霍奇金淋巴瘤患者占队列的近40%。 -----结果 ud udPICC的总停留时间为14781天,中位数为129天(范围8-570天)。成功重新定位或重新插入的12例患者(11.4%)发生了PICC定位不良。在39例患者(37%)中,由于怀疑或证实感染而在治疗结束前切除了PICC(30例患者,29%;每1000 PICC天2.03例),其中4例与PICC相关的血栓形成(3.8%), PICC(两名患者),导管放错位置(两名患者)和一名患者中疑似血栓栓塞。 -----结论 ud udPICC是血液恶性肿瘤患者的安全,方便的长期静脉通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号